Scilex Holding Company Retains Warshaw Burstein, LLP and Christian Attar … – MarketScreener

… back pain, with FDA Fast Track status. We received our SP-103 Phase 2 top-line results in August 2023 and the trial achieved its objectives …
Source: back pain